IBM (NYSE: IBM) Watson Health and Pfizer Inc. (NYSE: PFE) have announced a collaboration that will utilize IBM Watson for Drug Discovery to help accelerate Pfizer's research in immuno-oncology, an approach to cancer treatment that uses the body's immune system to help fight cancer.

Nuritas, the Irish digital-biotechnology and R&D company founded by Dr Nora Khaldi, has announced it will triple its workforce in Ireland to over 60 in 2017 as part of a major expansion of its Irish operations. It has also confirmed U2 band members Bono and The Edge as investors in the company.

The Wyss Center, a not-for-profit neurotechnology organization based in Geneva, Switzerland, has launched a global neurotech innovation challenge to connect the human brain with the digital world. The Challenge seeks the most disruptive new technologies for brain stimulation and neural signal recording. The goal is to develop technology with a clinical application that could help paralyzed people move, overcome depression or memory loss, restore vision or address other nervous system disorders.

iMDsoft®, a global leader in clinical information systems, today announced that it has been acquired by Harris Computer Corporation, an arm of the Constellation Software group. iMDsoft will be run as an independent business unit within Harris. It will be led by Shahar Sery, a seasoned iMDsoft executive, who has been nominated to the role of Executive Vice President.

CUBE, the global digital transformation ecosystem, has announced the biggest ever cash prize for a startup competition. CUBE is a global tech ecosystem that aims to promote, create and foster partnerships between industry players and startups worldwide. Born out of existing industry needs, CUBE focuses on cross industries ranging from life sciences to manufacturing, supported by key industry players like Bayer and Volkswagen.

Scottish clinical and translational informatics company Aridhia, Netherlands-based ICT service provider Vancis, and clinical datasets experts MGRID are today announcing the expansion of their existing partnership with the launch of a new research platform service, RSRCH-Health, into the Netherlands.

A technology developed in the UK has been selected for a national NHS acceleration programme to help measure if care is making a meaningful difference to people and to empower the NHS to prevent diseases, reduce severe illness and improve quality of life.

NHS England Medical Director Professor Sir Bruce Keogh and US digital health expert Professor Robert Wachter revealed in November eight health innovations to join the NHS Innovation Accelerator for 2016.